Table 2.

Demographic and clinical parameters for study participants

Patient number	Race	Age	Baseline FEV1	BAL Eosinophils (Pre-Challenge) %	BAL Eosinophils (Post-Challenge) %
1	Caucasian/Non-Hispanic	29	3.30 L/102.7%	0%	5%
2	Caucasian/Hispanic	21	3.44 L/89.6%	0.2%	76.1%
3	Black/Non-Hispanic	24	3.09 L/87.0%	0%	0.2%
4	Caucasian/Non-Hispanic	28	4.23 L/82.2%	0%	84.9%